These findings provide the emerging physiologic evidence in support of the role of FATS as an E2-independent E3 toward p53, in addition to pinpointing a genetic marker with potential value in predicting breast cancer risk in women with parity ≥3. This evidence concerns the gene TP53 and breast carcinoma.